Thu04172014

Last update 08:29:07 PM EST

BioRx Offers Health Outcomes Reporting Program for Primary Immune Deficiencies

BioRx Offers Health Outcomes Reporting Program for Primary Immune Deficiencies

National specialty pharmacy provider BioRx announc...

NeoStem to Acquire California Stem Cell

NeoStem to Acquire California Stem Cell

NeoStem, Inc. recently announced that it has enter...

Chinese Herbal Remedy Shows Promise as Rheumatoid Arthritis Treatment

Chinese Herbal Remedy Shows Promise as Rheumatoid Arthritis Treatment

A Chinese medical herb, known as thunder god vine,...

FDA Approves GlaxoSmithKline's GLP-1 Diabetes Drug Tanzeum

FDA Approves GlaxoSmithKline's GLP-1 Diabetes Drug Tanzeum

Today, the US Food and Drug Administration (FDA) a...

Bristol-Myers Squibb Submits NDA for HIV-1 Single Tablet Combination Drug

Bristol-Myers Squibb Submits NDA for HIV-1 Single Tablet Combination Drug

Today, Bristol-Myers Squibb Company announced that it has recently submitted a n...

Boehringer Ingelheim's Volasertib Receives Orphan Drug Designation from US and European Regulators

Boehringer Ingelheim's Volasertib Receives Orphan Drug Designation from US and European Regulators

Today, Boehringer Ingelheim announced that both the US Food and Drug Administrat...

Pfizer and AstraZeneca Partner with Cancer Research UK for Revolutionary Lung Cancer Trial

Pfizer and AstraZeneca Partner with Cancer Research UK for Revolutionary Lung Cancer Trial

Pfizer and AstraZeneca have joined the Cancer Research UK on the “National Lung ...

Karyopharm Initiates Phase I Study of KPT-330 in Acute Myeloid Leukemia Patients

Karyopharm Initiates Phase I Study of KPT-330 in Acute Myeloid Leukemia Patients

Karyopharm Therapeutics Inc. recently announced the initiation of an early-stage...

Dendreon Presents Preliminary Data from a Long-Term Analysis of its Prostate Cancer Study

Dendreon Presents Preliminary Data from a Long-Term Analysis of its Prostate Cancer Study

Dendreon Corporation recently presented data from a long-term analysis of a mid-...

Intercept's Rare Liver Disease Product Demonstrates Positive Results in Late-Stage Study

Intercept's Rare Liver Disease Product Demonstrates Positive Results in Late-Stage Study

Intercept Pharmaceuticals, Inc. recently announced efficacy and safety results f...

FDA Approves GlaxoSmithKline's GLP-1 Diabetes Drug Tanzeum

FDA Approves GlaxoSmithKline's GLP-1 Diabetes Drug Tanzeum

Today, the US Food and Drug Administration (FDA) approved GlaxoSmithKline’s (GSK...

Epirus to Merge with Zalicus

Epirus to Merge with Zalicus

Epirus Biopharmaceuticals and Zalicus recently announced that they have entered ...

CPPA Launches New Practice Accreditation Program for Community Pharmacies

CPPA Launches New Practice Accreditation Program for Community Pharmacies

Today, The Center for Pharmacy Practice Accreditation (CPPA) announced the launc...

BioAlliance Pharma and Topotarget Merge to Create A Leading Orphan Oncology Company

BioAlliance Pharma and Topotarget Merge to Create A Leading Orphan Oncology Company

Today, BioAlliance Pharma SA and Topotarget A/S announced their intention to mer...

NeoStem to Acquire California Stem Cell

NeoStem to Acquire California Stem Cell

NeoStem, Inc. recently announced that it has entered into a definitive agreement...

IMS Health Report Finds Growth in US Healthcare Services and Spending

IMS Health Report Finds Growth in US Healthcare Services and Spending

In 2013, Americans used more healthcare services and spent more money on prescri...

Certified Specialty Pharmacy Exams Underway

Certified Specialty Pharmacy Exams Underway

Alexandria, VA, April 15, 2014—The Specialty Pharmacy Certification Board (SPCB)...

J&J and Scripps Collaborate on New Drug Discovery Initiative

J&J and Scripps Collaborate on New Drug Discovery Initiative

The Scripps Research Institute (TSRI) announced the formation of a new drug disc...

Home Solutions Acquires Best Healthcare Services

Home Solutions Acquires Best Healthcare Services

Today, Home Solutions Infusion Therapy, a leading provider of specialty home inf...

BioRx Offers Health Outcomes Reporting Program for Primary Immune Deficiencies

BioRx Offers Health Outcomes Reporting Program for Primary Immune Deficiencies

National specialty pharmacy provider BioRx announced that it has expanded its Bi...

Galapagos and GlaxoSmithKline's Psoriasis Candidate Succeeds in Phase 2a Study

Galapagos and GlaxoSmithKline's Psoriasis Candidate Succeeds in Phase 2a Study

Today, Belgium-based biotechnology company Galapagos NV announced that UK-based ...

Chinese Herbal Remedy Shows Promise as Rheumatoid Arthritis Treatment

Chinese Herbal Remedy Shows Promise as Rheumatoid Arthritis Treatment

A Chinese medical herb, known as thunder god vine, eased the pain and inflammati...

Baxter's BAX 111 Meets Primary Endpoint in Phase III Von Willebrand Disease Trial

Baxter's BAX 111 Meets Primary Endpoint in Phase III Von Willebrand Disease Trial

A day before World Hemophilia Day, Baxter International Inc. announced that its ...